Advertisement
Advertisement
ELV
Elevance Health, Inc.
391.24
USDSponsored
+13.24
+3.50%
Aug 05, 15:59 UTC -4
Closed
Pre-Market
390.27
-0.97
-0.25%
ELV Earnings Reports
Positive Surprise Ratio
ELV beat 32 of 42 last estimates.
76%
Next Report
Date of Next Report
Oct 19, 2026
Estimate for Q3 26 (Revenue/ EPS)
$49.67B
/$4.69
Implied change from Q2 26 (Revenue/ EPS)
-0.31%
/-37.05%
Implied change from Q3 25 (Revenue/ EPS)
-0.83%
/-22.22%
Elevance Health, Inc. earnings per share and revenue
On Jul 15, 2026, ELV reported earnings of 7.45 USD per share (EPS) for Q2 26, beating the estimate of 6.26 USD, resulting in a 18.85% surprise. Revenue reached 49.83 billion, compared to an expected 49.19 billion, with a 1.30% difference. The market reacted with a -8.54% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 19 analysts forecast an EPS of 4.69 USD, with revenue projected to reach 49.67 billion USD, implying an decrease of -37.05% EPS, and decrease of -0.31% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
CVS HEALTH CORPORATION
Report Date
Aug 05, 2026 For Q2 26
Estimate
$1.87
Actual
$2.58
Surprise
+37.95%
Cencora, Inc.
Report Date
Aug 05, 2026 For Q3 26
Estimate
$4.39
Actual
$4.48
Surprise
+1.99%
Solventum Corporation
Report Date
Aug 05, 2026 For Q2 26
Estimate
$1.94
Actual
$2.54
Surprise
+31.15%
Revvity, Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$1.24
Actual
$1.41
Surprise
+13.09%
Charles River Laboratories International, Inc.
Report Date
Aug 05, 2026 For Q2 26
Estimate
$2.76
Actual
$3.02
Surprise
+9.38%
Caris Life Sciences, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.01
Actual
$0.00
Surprise
-100.00%
GoodRx Holdings, Inc. Class A Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.08
Actual
$0.08
Surprise
-0.99%
COMPASS Pathways Plc - ADR
Report Date
Aug 05, 2026 For Q2 26
Estimate
-$0.40
Actual
-$0.36
Surprise
+11.13%
agilon health, inc.
Report Date
Aug 05, 2026 For Q2 26
Estimate
-$0.12
Actual
$1.04
Surprise
+940.06%
LifeMD, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.16
Surprise
-7.67%
FAQ
What were Elevance Health, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Elevance Health, Inc. reported EPS of $7.45, beating estimates by 18.85%, and revenue of $49.83B, 1.3% above expectations.
How did the market react to Elevance Health, Inc.'s Q2 2026 earnings?
The stock price moved down -8.54%, changed from $426.79 before the earnings release to $390.33 the day after.
When is Elevance Health, Inc. expected to report next?
The next earning report is scheduled for Oct 19, 2026.
What are the forecasts for Elevance Health, Inc.'s next earnings report?
Based on 19
analysts, Elevance Health, Inc. is expected to report EPS of $4.69 and revenue of $49.67B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement